COMPOSITIONS AND METHODS FOR STIMULATING MEGAKARYOCYTE GROWTH AND DIFFERENTIATION

Disclosed are novel proteins, referred to as megakaryocyte growth and development factors (MGDFs; also generally referred to as Mpl ligands), that have a biological activity of stimulating the growth of megakaryocytes and augmenting the differentiation or maturation of megakaryocytes, ultimately to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JAKOB M. BOGENBERGER, TIMOTHY D. BARTLEY, OLAF B. KINSTLER, BABRU B. SAMAL, ROBERT A. BOSSELMAN, PAMELA HUNT
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JAKOB M. BOGENBERGER
TIMOTHY D. BARTLEY
OLAF B. KINSTLER
BABRU B. SAMAL
ROBERT A. BOSSELMAN
PAMELA HUNT
description Disclosed are novel proteins, referred to as megakaryocyte growth and development factors (MGDFs; also generally referred to as Mpl ligands), that have a biological activity of stimulating the growth of megakaryocytes and augmenting the differentiation or maturation of megakaryocytes, ultimately to result in the production of platelets. MGDF derivatives comprising MGDF molecules attached to water-soluble polymers, such as polyethylene glycol, are also disclosed, along with methods for their preparation. Also disclosed are processes for obtaining the MGDFs in homogeneous form from natural sources and producing them by recombinant genetic engineering techniques from mammals, including humans. Se describen las proteínas novedosas, denominadas como factores de crecimiento y desarrollo de megacariocitos (MGDFs; también en general denominadas como ligandos de Mp1), que tienen actividad biologica de estimulacion del crecimiento de megacariocitos y aumento de la diferenciacion o maduracion de megacariocitos, que al final dan como resultado la produccion de plaquetas. Los derivados de MGDF que comprenden moléculas de MGDF unidas a polímeros solubles en agua, tales como polietilenglicol son también descritos, junto con los métodos para su produccion. También se describen los procesos para la obtencion de los MGDFs en forma homogénea a partir de fuentes naturales, y produciéndolos mediante técnicas recombinantes de ingeniería genética a partir de mamíferos, incluyendo humanos.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX9600206A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX9600206A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX9600206A3</originalsourceid><addsrcrecordid>eNrjZAh09vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggO8fQN9XEM8fRzB4q7O3o7BkX6O0eGuCq4B_mHh3iANbh4urm5Brn6hXg6gkzhYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxvhGWZgYGRgZmjsaEVQAANTovLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR STIMULATING MEGAKARYOCYTE GROWTH AND DIFFERENTIATION</title><source>esp@cenet</source><creator>JAKOB M. BOGENBERGER ; TIMOTHY D. BARTLEY ; OLAF B. KINSTLER ; BABRU B. SAMAL ; ROBERT A. BOSSELMAN ; PAMELA HUNT</creator><creatorcontrib>JAKOB M. BOGENBERGER ; TIMOTHY D. BARTLEY ; OLAF B. KINSTLER ; BABRU B. SAMAL ; ROBERT A. BOSSELMAN ; PAMELA HUNT</creatorcontrib><description>Disclosed are novel proteins, referred to as megakaryocyte growth and development factors (MGDFs; also generally referred to as Mpl ligands), that have a biological activity of stimulating the growth of megakaryocytes and augmenting the differentiation or maturation of megakaryocytes, ultimately to result in the production of platelets. MGDF derivatives comprising MGDF molecules attached to water-soluble polymers, such as polyethylene glycol, are also disclosed, along with methods for their preparation. Also disclosed are processes for obtaining the MGDFs in homogeneous form from natural sources and producing them by recombinant genetic engineering techniques from mammals, including humans. Se describen las proteínas novedosas, denominadas como factores de crecimiento y desarrollo de megacariocitos (MGDFs; también en general denominadas como ligandos de Mp1), que tienen actividad biologica de estimulacion del crecimiento de megacariocitos y aumento de la diferenciacion o maduracion de megacariocitos, que al final dan como resultado la produccion de plaquetas. Los derivados de MGDF que comprenden moléculas de MGDF unidas a polímeros solubles en agua, tales como polietilenglicol son también descritos, junto con los métodos para su produccion. También se describen los procesos para la obtencion de los MGDFs en forma homogénea a partir de fuentes naturales, y produciéndolos mediante técnicas recombinantes de ingeniería genética a partir de mamíferos, incluyendo humanos.</description><edition>6</edition><language>eng ; spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; DERIVATIVES THEREOF ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; SUGARS ; VINEGAR ; WINE</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19981130&amp;DB=EPODOC&amp;CC=MX&amp;NR=9600206A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25555,76308</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19981130&amp;DB=EPODOC&amp;CC=MX&amp;NR=9600206A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JAKOB M. BOGENBERGER</creatorcontrib><creatorcontrib>TIMOTHY D. BARTLEY</creatorcontrib><creatorcontrib>OLAF B. KINSTLER</creatorcontrib><creatorcontrib>BABRU B. SAMAL</creatorcontrib><creatorcontrib>ROBERT A. BOSSELMAN</creatorcontrib><creatorcontrib>PAMELA HUNT</creatorcontrib><title>COMPOSITIONS AND METHODS FOR STIMULATING MEGAKARYOCYTE GROWTH AND DIFFERENTIATION</title><description>Disclosed are novel proteins, referred to as megakaryocyte growth and development factors (MGDFs; also generally referred to as Mpl ligands), that have a biological activity of stimulating the growth of megakaryocytes and augmenting the differentiation or maturation of megakaryocytes, ultimately to result in the production of platelets. MGDF derivatives comprising MGDF molecules attached to water-soluble polymers, such as polyethylene glycol, are also disclosed, along with methods for their preparation. Also disclosed are processes for obtaining the MGDFs in homogeneous form from natural sources and producing them by recombinant genetic engineering techniques from mammals, including humans. Se describen las proteínas novedosas, denominadas como factores de crecimiento y desarrollo de megacariocitos (MGDFs; también en general denominadas como ligandos de Mp1), que tienen actividad biologica de estimulacion del crecimiento de megacariocitos y aumento de la diferenciacion o maduracion de megacariocitos, que al final dan como resultado la produccion de plaquetas. Los derivados de MGDF que comprenden moléculas de MGDF unidas a polímeros solubles en agua, tales como polietilenglicol son también descritos, junto con los métodos para su produccion. También se describen los procesos para la obtencion de los MGDFs en forma homogénea a partir de fuentes naturales, y produciéndolos mediante técnicas recombinantes de ingeniería genética a partir de mamíferos, incluyendo humanos.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAh09vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggO8fQN9XEM8fRzB4q7O3o7BkX6O0eGuCq4B_mHh3iANbh4urm5Brn6hXg6gkzhYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxvhGWZgYGRgZmjsaEVQAANTovLg</recordid><startdate>19981130</startdate><enddate>19981130</enddate><creator>JAKOB M. BOGENBERGER</creator><creator>TIMOTHY D. BARTLEY</creator><creator>OLAF B. KINSTLER</creator><creator>BABRU B. SAMAL</creator><creator>ROBERT A. BOSSELMAN</creator><creator>PAMELA HUNT</creator><scope>EVB</scope></search><sort><creationdate>19981130</creationdate><title>COMPOSITIONS AND METHODS FOR STIMULATING MEGAKARYOCYTE GROWTH AND DIFFERENTIATION</title><author>JAKOB M. BOGENBERGER ; TIMOTHY D. BARTLEY ; OLAF B. KINSTLER ; BABRU B. SAMAL ; ROBERT A. BOSSELMAN ; PAMELA HUNT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX9600206A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>1998</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JAKOB M. BOGENBERGER</creatorcontrib><creatorcontrib>TIMOTHY D. BARTLEY</creatorcontrib><creatorcontrib>OLAF B. KINSTLER</creatorcontrib><creatorcontrib>BABRU B. SAMAL</creatorcontrib><creatorcontrib>ROBERT A. BOSSELMAN</creatorcontrib><creatorcontrib>PAMELA HUNT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JAKOB M. BOGENBERGER</au><au>TIMOTHY D. BARTLEY</au><au>OLAF B. KINSTLER</au><au>BABRU B. SAMAL</au><au>ROBERT A. BOSSELMAN</au><au>PAMELA HUNT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR STIMULATING MEGAKARYOCYTE GROWTH AND DIFFERENTIATION</title><date>1998-11-30</date><risdate>1998</risdate><abstract>Disclosed are novel proteins, referred to as megakaryocyte growth and development factors (MGDFs; also generally referred to as Mpl ligands), that have a biological activity of stimulating the growth of megakaryocytes and augmenting the differentiation or maturation of megakaryocytes, ultimately to result in the production of platelets. MGDF derivatives comprising MGDF molecules attached to water-soluble polymers, such as polyethylene glycol, are also disclosed, along with methods for their preparation. Also disclosed are processes for obtaining the MGDFs in homogeneous form from natural sources and producing them by recombinant genetic engineering techniques from mammals, including humans. Se describen las proteínas novedosas, denominadas como factores de crecimiento y desarrollo de megacariocitos (MGDFs; también en general denominadas como ligandos de Mp1), que tienen actividad biologica de estimulacion del crecimiento de megacariocitos y aumento de la diferenciacion o maduracion de megacariocitos, que al final dan como resultado la produccion de plaquetas. Los derivados de MGDF que comprenden moléculas de MGDF unidas a polímeros solubles en agua, tales como polietilenglicol son también descritos, junto con los métodos para su produccion. También se describen los procesos para la obtencion de los MGDFs en forma homogénea a partir de fuentes naturales, y produciéndolos mediante técnicas recombinantes de ingeniería genética a partir de mamíferos, incluyendo humanos.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX9600206A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
VINEGAR
WINE
title COMPOSITIONS AND METHODS FOR STIMULATING MEGAKARYOCYTE GROWTH AND DIFFERENTIATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A48%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JAKOB%20M.%20BOGENBERGER&rft.date=1998-11-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX9600206A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true